Dose and blood levels of haloperidol in treatment of mania
Rifkin, A.; Karajgi, B.; Doddi, S.; Cooper, T.
Psychopharmacology Bulletin 26(1): 144-146
1990
ISSN/ISBN: 0048-5764 PMID: 2371369 Document Number: 358852
Three doses of haloperidol, 10 mg/day, 30 mg/day, and 80 mg/day, were compared in 47 newly admitted manic patients. There was no difference in outcome within 6 weeks among the three doses. Four blood levels of plasma and red blood cell (RBC) haloperidol and reduced haloperidol showed no linear or curvilinear relationships to clinical response.
Document emailed within 1 workday
Related Documents
Belmaker, R.H.; Zohar, J.; Rimon, R.; Averbuch, I. 1984: Cyclic AMP and GMP in the cerebrospinal fluid after high-dose haloperidol treatment Polish Journal of Pharmacology and Pharmacy 36(2-3): 217-220Bowden, C.L.; Brugger, A.M.; Swann, A.C.; Calabrese, J.R.; Janicak, P.G.; Petty, F.; Dilsaver, S.C.; Davis, J.M.; Rush, A.J.; Small, J.G. 1994: Efficacy of divalproex vs lithium and placebo in the treatment of mania. the Depakote Mania Study Group JAMA 271(12): 918-924
Christman, R.S.; Weinstein, R.A.; Larose, J.B. 1974: Low-dose haloperidol as antiemetic treatment in gastrointestinal disorders: a double-blind study Current Therapeutic Research 16(11): 1171-1176
Ereshefsky, L.; Saklad, S.R.; Tran-Johnson, T.; Toney, G.; Lyman, R.C.; Davis, C.M. 1990: Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen Psychopharmacology Bulletin 26(1): 108-114
Singer, H.S.; Rabins, P.; Tune, L.E.; Coyle, J.T. 1981: Serum haloperidol levels in Gilles de la Tourette syndrome Biological Psychiatry 16(1): 79-84
Cannon, D.J.; McMillan, D.E.; Newton, J.E.; Fody, E.P.; Metzer, W.S.; Claybrook, M.; Couch, L.; Paige, S.R. 1988: Serum haloperidol and neuroleptic receptor levels in chronic psychosis Annals of Clinical and Laboratory Science 18(5): 378-383
Wei, F.C.; Jann, M.W.; Lin, H.N.; Piao-Chien, C.; Chang, W.H. 1996: A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy Journal of Clinical Psychiatry 57(7): 298-302
Otero, M.J.; Barrueco, M.; Mariño, E.L.; Gómez, F.; Domínquez-Gil, A. 1984: Serum levels, dose and response in prolonged treatment with theophylline Medicina Clinica 83(11): 447-449
Schaffer, C.B.; Batra, K.; Garvey, M.J.; Mungas, D.M.; Schaffer, L.C. 1984: The effect of haloperidol on serum levels of lithium in adult manic patients Biological Psychiatry 19(10): 1495-1499
Bigelow, L.B.; Kirch, D.G.; Braun, T.; Korpi, E.R.; Wagner, R.L.; Zalcman, S.; Wyatt, R.J. 1985: Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study Psychopharmacology Bulletin 21(1): 66-68
Creaven, P.J.; Allen, L.M.; Muggia, F.M. 1972: Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity Cancer ChemoTherapy Reports 56(5): 573-578
Jing, Q.Y.; Liu, Z.D.; Yang, Y.Q.; Shan, C.Y.; Wang, D.B.; Jiang, Y.M. 1982: Dynamic observations of blood sugar and insulin levels with low-dose insulin infusion Chinese Medical Journal 95(12): 915-920
Pullar, T.; Hunter, J.A.; Capell, H.A. 1985: Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy British Journal of Rheumatology 24(3): 269-276
Andréjak, M.; Zannad, Fïez.; Laville, M.; Duru, Gérard.; Mourad, J-Jacques.; Waeber, B. 2003: Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment Therapie 58(4): 351-352
Nagao, M.; Kanamori, M.; Takatori, T.; Terazawa, K.; Gotouda, H. 1987: An attempt on removal of haloperidol in plasma by use of anti-haloperidol immunoadsorbent Nihon Hoigaku Zasshi 41(3): 232-235
Leff, J.P.; Tress, K.H. 1986: The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate International Clinical Psychopharmacology 1(Suppl 1): 27-40
Kal'tianis, P.A. 1985: Urinary levels of antibacterial preparations during anti-relapse low-dose treatment of children with pyelonephritis Pediatriia 10: 42-44
Van den Wijngaart, W.; Verbrugh, H.; Theopold, H.M.; Bauernfeind, A.; Cuenant, G.; Duval, I.; Wilber, R.B.; Durham, S.J.; Hamilton, H.; Van Gysel, P. 1992: A noncomparative study of cefprozil at two dose levels in the treatment of acute uncomplicated bacterial sinusitis Clinical Therapeutics 14(2): 306-313
Altamura, A.C.; Buccio, M.; Colacurcio, F.; Colombo, G.; Terzi, A. 1986: Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol Acta Neurologica 8(1): 19-26
Khedun, S.M.; Maharaj, B.; Naicker, T. 1996: The effect of a low dose versus a conventional dose of hydrochlorothiazide on ventricular fibrillation threshold and electrolyte levels in laboratory rats Brazilian Journal of Medical and Biological Research 29(10): 1373-1378